210 results on '"Mamtani, Anita"'
Search Results
2. Mutational Status is Associated with a Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer
3. ASO Visual Abstract: Mutational Status is Associated with Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer
4. Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?
5. Do non-classic invasive lobular carcinomas derive a benefit from neoadjuvant chemotherapy?
6. Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy
7. Outcomes of Breast Cancer Patients with High Volume of Residual Disease Following Neoadjuvant Chemotherapy
8. The Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer
9. Local Recurrence is Frequent After Heroic Mastectomy for Classically Inoperable Breast Cancers
10. Margin Width and Local Recurrence in Patients Undergoing Breast Conservation After Neoadjuvant Chemotherapy
11. ASO Visual Abstract: Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy
12. ASO Author Reflections: Avoiding Overtreatment: Benefits of Selective Use of Frozen Sections Among cN0 Breast Cancer Patients Having Upfront Mastectomy
13. Surgical Margins in Breast-Conserving Surgery
14. Adoption of SSO-ASTRO Margin Guidelines for Ductal Carcinoma in Situ: What Is the Impact on Use of Additional Surgery?
15. ASO Visual Abstract: Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer
16. Extranodal Tumor Deposits in the Axillary Fat Indicate the Need for Axillary Dissection Among T1–T2cN0 Patients with Positive Sentinel Nodes
17. Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy
18. Treatment of Ductal Carcinoma In Situ: Considerations for Tailoring Therapy in the Contemporary Era
19. Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion
20. Is Clinical Exam of the Axilla Sufficient to Select Node-Positive Patients Who Downstage After NAC for SLNB? A Comparison of the Accuracy of Clinical Exam Versus MRI
21. ASO Author Reflections: Heroic Mastectomy for Chemoresistant Disease: A Complex Decision
22. ASO Visual Abstract: Local Recurrence is Frequent After Heroic Mastectomy for Classically Inoperable Breast Cancers
23. Lobular Breast Cancer: Different Disease, Different Algorithms?
24. Was Reexcision Less Frequent for Patients with Lobular Breast Cancer After Publication of the SSO-ASTRO Margin Guidelines?
25. Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers
26. ASO Visual Abstract: Margin Width and Local Recurrence in Patients Undergoing Breast Conservation after Neoadjuvant Chemotherapy
27. ASO Author Reflections: Evolving Paradigms in the Treatment of DCIS: Impact of the SSO-ASTRO Margin Guidelines
28. Treatment Strategies in Octogenarians with Early-Stage, High-Risk Breast Cancer
29. ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone
30. ASO Author Reflections: Advising a Woman with Ductal Carcinoma In Situ Regarding Various Treatment Options—A Complex Decision
31. ASO Author Reflections: Early-Stage Lobular Breast Cancer: Axillary Treatment in the Z0011 Era
32. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review
33. The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype
34. Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?
35. Is Routine Axillary Imaging Necessary in Clinically Node-Negative Patients Undergoing Neoadjuvant Chemotherapy?
36. Targeted Therapy and Local Control: The Dynamic Duo
37. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study
38. Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center
39. Early-Stage Breast Cancer in the Octogenarian: Tumor Characteristics, Treatment Choices, and Clinical Outcomes
40. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases
41. How Often Is Treatment Effect Identified in Axillary Nodes with a Pathologic Complete Response After Neoadjuvant Chemotherapy?
42. Nuclear Stat5a/b predicts early recurrence and prostate cancer–specific death in patients treated by radical prostatectomy
43. Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients
44. Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy—A Rare Event
45. Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?
46. ASO Author Reflections: Heroic Mastectomy for Chemoresistant Disease: A Complex Decision
47. Local Recurrence is Frequent After Heroic Mastectomy for Classically Inoperable Breast Cancers
48. Erratum to: Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer
49. Margin Width and Local Recurrence in Patients Undergoing Breast Conservation After Neoadjuvant Chemotherapy
50. A test of the role of two prefrontal/ subcortical networks in the “sequencing” of non-motor, visuo-spatial information
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.